Blog
RSS FeedPosted by Michael Wonder on 18 Apr 2021
Greg Hunt confirms ‘high interest’ in producing mRNA vaccines onshore
18 April 2021 - Australia is interested in producing a cutting-edge form of vaccines in Australia, after the nation’s rollout was ...
Posted by Michael Wonder on 18 Apr 2021
Vaccines for over-50s to be brought forward as national cabinet reconfigures rollout
18 April 2021 - People aged over 50 could be vaccinated sooner and more mass-vaccination sites opened to speed up ...
Posted by Michael Wonder on 16 Apr 2021
AstraZeneca ChAdOx1-S COVID-19 vaccine
16 April 2021 - Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine. ...
Posted by Michael Wonder on 15 Apr 2021
Australian population unlikely to be vaccinated until end of next year
15 April 2021 - Leading public health experts have warned the Australian population is unlikely to get COVID-19 vaccinations until ...
Posted by Michael Wonder on 15 Apr 2021
EU drug regulator to issue view on J&J vaccine next week
15 April 2021 - Europe's drug regulator said on Wednesday it planned to issue a recommendation on Johnson & Johnson's ...
Posted by Michael Wonder on 15 Apr 2021
Health Canada stands by approval of AstraZeneca, Johnson & Johnson COVID-19 vaccines
14 April 2021 - Health Canada is standing by the approval of the Oxford-AstraZeneca and Johnson & Johnson vaccines for ...
Posted by Michael Wonder on 15 Apr 2021
Central Coast woman’s death after COVID-19 vaccine being investigated
15 April 2021 - Federal health authorities are investigating the death of a woman days after she received a COVID-19 ...
Posted by Michael Wonder on 15 Apr 2021
Public consultation – draft 2021-22 Cost Recovery Implementation Statement for listing medicines on the PBS and designated vaccines on the NIP
15 April 2021 - Consultation on the content of the draft Cost Recovery Implementation Statement for listing medicines on the ...
Posted by Michael Wonder on 14 Apr 2021
New blow to rollout as Novavax Covid-19 vaccine hits supply hiccup
15 April 2021 - Australia’s vaccine rollout has been dealt another blow as Novavax confirms manufacturing supply shortages mean it ...
Posted by Michael Wonder on 14 Apr 2021
Europe bets heavily on Pfizer in vaccine strategy overhaul
15 April 2021 - Europe has hinted it will not renew contracts for coronavirus vaccines produced by pharmaceutical giants AstraZeneca ...
Posted by Michael Wonder on 14 Apr 2021
Novavax COVID-19 vaccine in Australia: When will we get it? And is it better than Pfizer?
14 April 2021 - Australia's sluggish vaccine rollout was last week thrown another curve ball, with new medical advice recommending ...
Posted by Michael Wonder on 14 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
14 April 2021 - EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination ...
Posted by Michael Wonder on 14 Apr 2021
COVID-19 vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
14 April 2021 - As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots ...
Posted by Michael Wonder on 14 Apr 2021
Batch release assessment of COVID-19 vaccines
14 April 2021 - The Therapeutic Goods Administration ensures there is an independent quality assessment of every batch of vaccine supplied ...
Posted by Michael Wonder on 13 Apr 2021
U.S. FDA to scrutinise vaccine design behind COVID-19 shots linked to blood clots
13 April 2021 - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood ...